Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects
Mohammed Hassan‐Alin(AstraZeneca (United Kingdom)), Kerstin Röhss(AstraZeneca (Sweden)), Mathias Liljeblad(AstraZeneca (Sweden)), Bjorn Persson, Tommy Andersson(Karolinska University Hospital), Mohammad Niazi
Cited by 18
Related Papers
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175
Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
|Molecular Pharmacology|1986|160
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
|British Journal of Clinical Pharmacology|1998|124
A Formylated Hexapeptide Ligand Mimics the Ability of Wnt-5a to Impair Migration of Human Breast Epithelial Cells
|Journal of Biological Chemistry|2005|115